Moxalactam pharmacokinetics during hemodialysis.

To establish dosage recommendations, moxalactam elimination kinetics were studied in six anephric patients during hemodialysis and in four anephric patients during the interdialytic period. After a single 1-g intravenous bolus injection, moxalactam elimination half-life was 18.0 plus or minus 0.6 h...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Aronoff, G R, Sloan, R S, Mong, S A, Luft, F C, Kleit, S A
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1981
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181480/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6454386/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.19.4.575
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!